# Nebulized Dexmedetomidine Versus Oral Sumatriptan in Treatment of Post Dural Puncture Headache in Cesarean Section

> **NCT06514040** · NA · COMPLETED · sponsor: **Fayoum University Hospital** · enrollment: 48 (actual)

## Conditions studied

- Post-Dural Puncture Headache

## Interventions

- **DRUG:** Precedex
- **DRUG:** Sumatriptan 25 mg

## Key facts

- **NCT ID:** NCT06514040
- **Lead sponsor:** Fayoum University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-27
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-09-30
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06514040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06514040, "Nebulized Dexmedetomidine Versus Oral Sumatriptan in Treatment of Post Dural Puncture Headache in Cesarean Section". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06514040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*